脑部放疗，上午比下午敏感许多！
* p5 B- u1 O: n3 W4 d3 Q& {3 b
0 R- v) c3 o( S9 R. l. e( R- f7 {# A
& M2 Y# ^9 N1 g, a" SCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
& Q! K" Q$ c; G5 M% TGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
1 O4 _& x! y' Z$ X$ } ERahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.' t4 h0 h# a$ |# F
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.+ x1 `; Q0 b) ?, V" B
4 s2 B! Y( n# O) m0 w! d3 LAbstract* c5 }1 n# L* P+ s, c! K
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
; b$ G" K# L" ~1 i2 q$ M' Y3 O" g
% o: k. l- \! [7 p( ?$ R9 q+ O2 ~, vMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.1 ~! Q4 j4 `1 B* h8 ^
: f7 H/ F; S' O+ [. { _: Y+ [
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026)." S1 H- n" z8 G- K
3 O$ B$ @ X/ ?( V/ }) H8 x
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.& W, d0 \+ j- o3 ?8 D
4 [. J6 t$ P9 T {7 z$ q% ` |
) X0 r5 P" W( j/ m
显身卡
